Goldman Sachs Upgrades Mylan (MYL) to Buy, Sees Earnings Revised Higher

February 14, 2012 7:17 AM EST
MYL Hot Sheet
Rating Summary:
    6 Buy, 3 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 24 | Down: 11 | New: 36
Goldman Sachs upgraded Mylan (NASDAQ: MYL) from Neutral to Buy with a price target of $27 (up from $23).

The firm said they have increased confidence in the company's earnings visibility, and they see Street estimates revised higher which will drive the stock. Goldman notes that investors have skeptical of the company's 2013 EPS target, given concerns about exposure to EU and Asia-Pacific generics which have see soft pricing.

While the firm lowered estimates further to account for these headwinds, they see the strategy to re-value its EpiPen brand franchise to more than offset and provide significant growth.

The firm sees FY11 EPS of $2.01, FY12 of $2.53 and FY13 of $2.70.

For an analyst ratings summary and ratings history on Mylan click here. For more ratings news on Mylan click here.

Shares of Mylan closed at $22.96 yesterday, with a 52 week range of $15.49-$25.46.


Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!

You May Also Be Interested In


Related Categories

Analyst PT Change, Hot Upgrades, Upgrades

Related Entities

Goldman Sachs, Earnings

Add Your Comment





Follow StreetInsider.com On Twitter